Last Updated: September 28, 2026

CHYMEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Chymex patents expire, and what generic alternatives are available?

Chymex is a drug marketed by Savage Labs and is included in one NDA.

The generic ingredient in CHYMEX is bentiromide. Additional details are available on the bentiromide profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CHYMEX?
  • What are the global sales for CHYMEX?
  • What is Average Wholesale Price for CHYMEX?
Summary for CHYMEX
US Patents:0
Applicants:1
NDAs:1

US Patents and Regulatory Information for CHYMEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs CHYMEX bentiromide SOLUTION;ORAL 018366-001 Dec 29, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CHYMEX

See the table below for patents covering CHYMEX around the world.

Country Patent Number Title Estimated Expiration
Belgium 775377 ⤷  Start Trial
Canada 1014551 SYNTHETIC POLYPEPTIDES ⤷  Start Trial
Germany 2156835 ⤷  Start Trial
France 2115246 ⤷  Start Trial
United Kingdom 1380904 ⤷  Start Trial
Japan S5323824 ⤷  Start Trial
Netherlands 173053 ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.